Lipidomics Market Analysis 2026

Global Lipidomics Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Lipidomics Market Report Description

We have various report editions of Lipidomics Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The April 2025 “Liberation Day Tariffs” (10–46%) have disrupted global pharmaceutical trade, raising costs for APIs, packaging, and machinery from China and India. Generic drug makers, biopharma, vaccines, and CMOs face higher expenses, supply chain delays, and regulatory hurdles, while EU retaliation has further strained U.S. exports. Clinical trials are also delayed due to tariffs on drugs and kits. In this landscape, market research is vital, providing real-time data on pricing, suppliers, and tariff impacts to help companies optimize supply chains, find alternative hubs, and maintain competitiveness.

Competitive Landscape of the Lipidomics Market

The competitive landscape of the lipidomics market is characterized by a mix of established companies and emerging players, each vying for market share in this rapidly growing field. Key players are focusing on strategic initiatives such as partnerships, collaborations, acquisitions, and product launches to strengthen their market position.

July 2020: Croda International Plc (Croda) confirms that, following approval from the US regulatory authorities, it has now successfully completed the acquisition of Avanti Polar Lipids, Inc., a leader in drug delivery systems for next-generation pharmaceuticals. (Source: https://www.croda.com/en-gb/investors/acquisitions/strengthening-life-sciences-with-the-acquisition-of-avanti-polar-lipids) March 2020:Waters Corporation and the University of Tokyo are collaborating on a lipidomics research project to provide a clearer picture of what it means to be healthy. Led by Prof. Yoshiya Oda from the Graduate School of Medicine at the University of Tokyo, the study is exploring the relationship between lipids and human health through the application of ion mobility-mass spectrometry (IMS-MS) technology. (Source: https://www.waters.com/blog/waters-and-the-university-of-tokyo-collaborate-on-lipidomics-research/)

Top Companies Market Share in Lipidomics Industry: (In no particular order of Rank)

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)

Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Lipidomics Market

Which Region Dominates the Lipidomics Market in 2024?

According to Cognitive Market Research, North America holds a dominant position in the Leukemia Molecular Diagnostic Market due to several factors. Firstly, the region boasts advanced healthcare infrastructure and a strong focus on research and development, enabling the early adoption of innovative diagnostic technologies. Secondly, the high prevalence of leukemia cases in North America drives the demand for accurate and efficient diagnostic tools. Additionally, favorable government initiatives and reimbursement policies further support market growth. Moreover, the presence of key market players and academic research institutions enhances the development and commercialization of molecular diagnostic products in the region.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific is the fastest-growing region in the Leukemia Molecular Diagnostic Market primarily due to several key factors. Firstly, the region has a large and growing population, leading to a higher prevalence of leukemia cases and thus increasing the demand for diagnostic solutions. Secondly, improving healthcare infrastructure and rising healthcare expenditure in countries like China, India, and Japan are driving the adoption of advanced diagnostic technologies. Thirdly, increasing awareness about the benefits of early diagnosis and treatment is fueling the demand for molecular diagnostic tests.

The current report Scope analyzes Lipidomics Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (East Africa, West Africa, North Africa, South Africa)

The above graph is for illustrative purposes only.

North America Lipidomics Market Analysis

According to Cognitive Market Research, the global Lipidomics market size was estimated at USD 55.9 Million,out of which North America held the major market of more than 40% of the global revenue with a market size of USD 22.36million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.0%from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Lipidomics market with a market size of USD 17.64 million in 2024 and is projected to grow at a CAGR of 6.8% during the forecast period. The demand is amplified by the nation's increasing research activities in lipid profiling.
• The Canada Lipidomics market had a market share of USD 2.68 million in 2024 and is projected to grow at a CAGR of 7.8% during the forecast period. Canada's rising prevalence of metabolic disorders.
• The Mexico Lipidomics market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 2.03 million in 2024.

Europe Lipidomics Market Analysis

According to Cognitive Market Research, the global Lipidomics market size was estimated at USD 55.9 Million out of which Europe held the market of more than 30% of the global revenue with a market size of USD 16.77million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.3%from 2024 to 2031.

• The United Kingdom Lipidomics market had a market share of USD 2.82 million in 2024 and is projected to grow at a CAGR of 8.1% during the forecast period. In the UK, Lipidomics sales witness an upswing due to the nation's increasing research initiatives in lipid metabolism.
• The France Lipidomics market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 1.54 million in 2024.
• According to Cognitive Market Research, the Germany Lipidomics market size was valued at USD 3.32 million in 2024 and is projected to grow at a CAGR of 7.5% during the forecast period. In Germany, Lipidomics sales surged due to the advanced healthcare infrastructure.
• The Italy Lipidomics market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 1.44 million in 2024.
• The Russia Lipidomics market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 2.60 million in 2024.
• The Spain Lipidomics market is projected to witness growth at a CAGR of 6.4% during the forecast period with a market size of USD 1.38 million in 2024
• The LuxembourgLipidomics market is projected to witness growth at a CAGR of 7.4% during the forecast period, with a market size of USD 0.52 million in 2024.
• The PortugalLipidomics market is projected to witness growth at a CAGR of 7.1% during the forecast period, with a market size of USD 0.35 million in 2024.
• The GreeceLipidomics market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 0.20 million in 2024.
• Rest of Europe'sLipidomics market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 2.60 million in 2024.

Asia Pacific Lipidomics Market Analysis

According to Cognitive Market Research, the global Lipidomics market size was estimated at USD 55.9Million, out of which Asia Pacific held the market ofaround23% of the global revenue with a market size of USD 12.86million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.8%from 2024 to 2031.

• According to Cognitive Market Research, the China Lipidomics market size was valued at USD 5.79 million in 2024 and is projected to grow at a CAGR of 10.3% during the forecast period. Lipidomics sales surge in China due to the growing healthcare expenditure.
• The Japan Lipidomics market is projected to witness growth at a CAGR of 9.3% during the forecast period, with a market size of USD 1.77 million in 2024.
• The India Lipidomics market had a market share of USD 1.54 million in 2024 and is projected to grow at a CAGR of 12.6% during the forecast period. India's rising prevalence of lifestyle-related disorders.
• The South Korea Lipidomics market is projected to witness growth at a CAGR of 9.9% during the forecast period, with a market size of USD 1.29 million in 2024.
• The Australia Lipidomics market is projected to witness growth at a CAGR of 10.5% during the forecast period, with a market size of USD 0.67 million in 2024.
• The South East Asia Lipidomics market is projected to witness growth at a CAGR of 11.8% during the forecast period, with a market size of USD 0.89 million in 2024.
• The Rest of Asia Pacific Lipidomics market is projected to witness growth at a CAGR of 10.6% during the forecast period, with a market size of USD 0.91 million in 2024.

South America Lipidomics Market Analysis

According to Cognitive Market Research, the global Lipidomics market size was estimated at USD 55.9 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 2.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.2%from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Lipidomics market size was valued at USD 1.20 million in 2024 and is projected to grow at a CAGR of 8.8% during the forecast period. Lipidomics sales flourish in Brazil due to the increasing research in lipid biomarkers.
• Argentina Lipidomics market had a market share of USD 0.47 million in 2024 and is projected to grow at a CAGR of 9.1% during the forecast period. Argentina's rising awareness of personalized medicine.
• Colombia Lipidomics market is projected to witness growth at a CAGR of 8.0% during the forecast period with a market size of USD 0.25 million in 2024.
• Peru Lipidomics market is projected to witness growth at a CAGR of 8.4% during the forecast period with a market size of USD 0.23 million in 2024.
• Chile Lipidomics market is projected to witness growth at a CAGR of 8.5% during the forecast period with a market size of USD 0.20 million in 2024.
• The Rest of Latin America Lipidomics market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 0.45 million in 2024.

Middle East Lipidomics Market Analysis

According to Cognitive Market Research, the global Lipidomics market size was estimated at USD 55.9 Million, out of which the Middle East and Africa held the major market ofaround 2% of the global revenue with a market size of USD 1.12million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.5%from 2024 to 2031

• The GCC Countries Lipidomics market is projected to witness growth at a CAGR of 9.3% during the forecast period with a market size of USD 0.48 million in 2024. Lipidomics sales flourish due to the increasing research focus on lipidomics.
• The Egypt Lipidomics market is projected to witness growth at a CAGR of 8.8% during the forecast period, with a market size of USD 0.12 million in 2024.
• The South Africa Lipidomics market is projected to witness growth at a CAGR of 9.5% during the forecast period, with a market size of USD 0.18 million in 2024. Lipidomics sales flourish in South Africa due to the rising adoption of advanced analytical technologies.
• The Turkey Lipidomics market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD 0.10 million in 2024.
• The Nigeria Lipidomics market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 0.12million in 2024.
• The Rest of MEA Lipidomics market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 0.13 million in 2024.

Author's Conclusion

Author's Detail

Supriya Yadav

Research Analyst

LinkedIn | Profile | Book Appointment

Supriya Yadav is a dedicated market research professional with expertise in the aerospace and defence industry. At Cognitive Market Research, she focuses on delivering strategic insights into aviation advancements, defence technologies, and global security trends shaping the future of the sector.

Her research covers areas such as military modernization, commercial aviation growth, space exploration, and defence procurement strategies. With a strong analytical mindset and attention to technological evolution, Supriya provides data-driven intelligence that supports innovation, strategic planning, and informed decision-making within the aerospace and defence domain.